{"id":195138,"date":"2026-07-21T03:42:12","date_gmt":"2026-07-21T09:12:12","guid":{"rendered":"https:\/\/newslink360.space\/?p=195138"},"modified":"2026-07-21T03:42:12","modified_gmt":"2026-07-21T09:12:12","slug":"emcure-biological-e-license-three-icmr-biomedical-technologies-for-commercial-use","status":"publish","type":"post","link":"https:\/\/newslink360.space\/?p=195138","title":{"rendered":"Emcure, Biological E License Three ICMR Biomedical Technologies For Commercial Use"},"content":{"rendered":"<p><br \/>\n<\/p>\n<div><strong>Market snapshot:<\/strong> The Indian Council of Medical Research (ICMR) has facilitated the licensing of three indigenous biomedical technologies to leading manufacturers Emcure Pharmaceuticals and Biological E. The tech transfers cover a novel anti-HPV candidate for cancer prevention and next-generation bacterial vaccines. These commercialisation pacts mark a critical step in bridging public research and market-ready clinical solutions.<\/p>\n<h2>Data Snapshot<\/h2>\n<ul>\n<li>Emcure Pharmaceuticals Q4 FY26 consolidated revenue stood at \u20b92,469.7 crore, registering a 16.7% growth compared to \u20b92,116.25 crore in the year-ago quarter.<\/li>\n<li>Emcure&#8217;s consolidated net profit for Q4 FY26 reached \u20b9243.74 crore, up 24% from \u20b9197.24 crore in the corresponding period of the previous fiscal year.<\/li>\n<li>Emcure&#8217;s full-year FY26 consolidated revenue stood at \u20b99,203.54 crore, growing 16.6% compared to \u20b97,896 crore in FY25.<\/li>\n<\/ul>\n<h2>What&#8217;s Changed<\/h2>\n<ul>\n<li>Emcure&#8217;s consolidated revenue for Q4 FY26 increased to \u20b92,469.7 crore from \u20b92,116.25 crore in Q4 FY25.<\/li>\n<li>Emcure&#8217;s consolidated net profit for Q4 FY26 grew to \u20b9243.74 crore from \u20b9197.24 crore in Q4 FY25.<\/li>\n<li>Emcure&#8217;s full-year FY26 net profit reached \u20b9941.27 crore compared to \u20b9707.47 crore in FY25.<\/li>\n<\/ul>\n<h2>Key Takeaways<\/h2>\n<ul>\n<li>Technology transfers for three homegrown biomedical solutions have been successfully finalized by ICMR.<\/li>\n<li>Emcure Pharmaceuticals secured the rights for SHetA2, an anti-HPV targeted therapeutic candidate for treating Cervical Intraepithelial Neoplasia (CIN).<\/li>\n<li>Biological E received the license for two vaccine technologies: a typhoid candidate (Salmonella typhi outer membrane protein construct) and a recombinant vaccine for Salmonella typhi\/paratyphi and Shigella infections.<\/li>\n<li>The licensing was executed under ICMR\u2019s Medical Innovations Patent Mitra initiative, fostering public-private healthcare commercialisation.<\/li>\n<\/ul>\n<h2>SAHI Perspective<\/h2>\n<p>Licensing public-funded medical IP is a structural win for India&#8217;s domestic pharmaceutical operators. For Emcure, obtaining SHetA2 bolsters its long-term specialty therapeutic oncology pipeline. This strategic acquisition positions the company to tap into a high-barrier clinical category with a targeted cervical cancer drug, complementing its existing strength in international markets. For Biological E, the multi-pathogen enteric vaccines build on its vaccine manufacturing prowess, addressing large-scale unmet public health needs globally.<\/p>\n<h2>Market Implications<\/h2>\n<p>This licensing deal enhances the specialty therapeutic assets of both companies, reinforcing investor sentiment regarding R&amp;D translation capabilities. The entry of indigenous therapies addresses India&#8217;s high cancer and infectious disease burden, reducing reliance on expensive imported chemical formulations and paving the way for affordable domestic healthcare solutions.<\/p>\n<h2>Trading Signals<\/h2>\n<p><strong>Market Bias:<\/strong> Bullish<\/p>\n<p>Emcure&#8217;s pipeline expansion through ICMR technology transfers strengthens its long-term product portfolio. This product momentum is strongly backed by the company&#8217;s fiscal health, where consolidated FY26 revenue reached \u20b99,203.54 crore.<\/p>\n<p><strong>Overweight:<\/strong> Pharmaceuticals, Healthcare, Biotechnology<\/p>\n<p><strong>Trigger Factors:<\/strong><\/p>\n<ul>\n<li>Successful initiation and outcomes of clinical trials for the newly in-licensed SHetA2 therapeutic candidate.<\/li>\n<li>Pricing and commercialisation timelines for Biological E&#8217;s enteric vaccines.<\/li>\n<li>Continuous execution of Emcure&#8217;s complex injectables and biosimilar pipelines.<\/li>\n<\/ul>\n<p><strong>Time Horizon:<\/strong> Medium-term (3\u201312 months)<\/p>\n<h2>Industry Context<\/h2>\n<p>The Indian formulation and oncology markets are undergoing a significant shift from volume-driven generics to innovation-led products. High-science therapeutic categories such as targeted oncology and multi-antigen recombinant vaccines represent premium margin drivers. Government-backed research transfers enable domestic manufacturers to commercialise proprietary research at significantly lower upfront R&amp;D costs.<\/p>\n<h2>Key Risks to Watch<\/h2>\n<ul>\n<li>Clinical and regulatory hurdles associated with advancing early-stage therapeutic candidates like SHetA2 through human clinical trials.<\/li>\n<li>Fierce competitive landscape from global innovators and generic manufacturers post patent-expiries.<\/li>\n<li>Underperformance or distribution delays in launching the next-generation enteric vaccines.<\/li>\n<\/ul>\n<h2>Recent Developments<\/h2>\n<p>On July 20, 2026, Emcure Pharmaceuticals announced that its semaglutide brand Poviztra is now available across India for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) in adults, following necessary regulatory approvals from the CDSCO. This rollout expands local access to treatments for progressive liver conditions.<\/p>\n<h2>Closing Insight<\/h2>\n<p>ICMR&#8217;s technology transfer to Emcure and Biological E demonstrates the commercial maturity of India&#8217;s indigenous biomedical R&amp;D. By securing high-impact, first-in-class pipeline candidates, both companies are structurally upgrading their long-term growth profiles.<\/p>\n<p><strong>High Performance Trading with SAHI.<\/strong>\n<\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.sahi.com\/news\/emcure-biological-e-license-three-icmr-biomedical-technologies-for-commercial-use-3127-PE1_COR\" target=\"_blank\" rel=\"noopener\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Market snapshot: The Indian Council of Medical Research (ICMR) has facilitated the licensing of three indigenous biomedical technologies to leading manufacturers Emcure Pharmaceuticals and Biological E. The tech transfers cover a novel anti-HPV candidate for cancer prevention and next-generation bacterial vaccines. These commercialisation pacts mark a critical step in bridging public research and market-ready clinical&#8230;<\/p>\n","protected":false},"author":1,"featured_media":195139,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7],"tags":[],"class_list":["post-195138","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-national-news"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/newslink360.space\/wp-content\/uploads\/2026\/07\/3127_PE_1_CORPORATE_21_07_2026_16x9_510c90db2d.jpg","jetpack_likes_enabled":true,"jetpack-related-posts":[{"id":194193,"url":"https:\/\/newslink360.space\/?p=194193","url_meta":{"origin":195138,"position":0},"title":"RIL Q2 FY27 results: Reliance Industries beats estimates with record quarterly EBITDA; revenue rises 25% yoy","author":"Ajay Kumar Verma","date":"July 17, 2026","format":false,"excerpt":"Mukesh Ambani (file photo) RIL results: Mukesh Ambani-led Reliance Industries Ltd (RIL), India's most valuable company, posted its highest-ever quarterly core profit and EBITDA for the June quarter, supported by robust performances from its oil-to-chemicals and telecom businesses.The oil-to-telecom conglomerate reported a 25.4% year-on-year increase in consolidated revenue to Rs\u2026","rel":"","context":"In &quot;National News&quot;","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/1784303931_photo.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/1784303931_photo.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/1784303931_photo.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/1784303931_photo.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/1784303931_photo.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":197769,"url":"https:\/\/newslink360.space\/?p=197769","url_meta":{"origin":195138,"position":1},"title":"Investment of Rs 40,000 crore, target of doubling sales in 5 years, this company will become a money printing machine for investors!","author":"Ajay Kumar Verma","date":"July 27, 2026","format":false,"excerpt":"Last Updated:July 08, 2026, 16:56 ISTTata Motors has presented a big roadmap for the next five years for its passenger vehicle business. The company will invest Rs 40,000 crore and wants to achieve the target of annual sales of more than 12 lakh vehicles by financial year 2031. Along with\u2026","rel":"","context":"In &quot;Top Stories&quot;","block_context":{"text":"Top Stories","link":"https:\/\/newslink360.space\/?cat=119"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/chandrasekaran-2026-06-5d1d1e1969919565d486d6688c46b1c9-1200x675.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/chandrasekaran-2026-06-5d1d1e1969919565d486d6688c46b1c9-1200x675.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/chandrasekaran-2026-06-5d1d1e1969919565d486d6688c46b1c9-1200x675.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/chandrasekaran-2026-06-5d1d1e1969919565d486d6688c46b1c9-1200x675.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/chandrasekaran-2026-06-5d1d1e1969919565d486d6688c46b1c9-1200x675.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":194157,"url":"https:\/\/newslink360.space\/?p=194157","url_meta":{"origin":195138,"position":2},"title":"Reliance Industries Q1 Results LIVE: Here&#8217;s what brokerages expect from the Mukesh Ambani company &#8211; Jio, Retail in focus","author":"Ajay Kumar Verma","date":"July 17, 2026","format":false,"excerpt":"Reliance Industries Q1 Results LIVE: Reliance Industries Ltd. (RIL) will be in the spotlight on Friday, July 17, as the oil-to-telecom conglomerate is scheduled to announce its financial results for the first quarter of FY27 after the close of market trading. Reliance Industries share price rose as much as 2.4%\u2026","rel":"","context":"In &quot;National News&quot;","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/RIL_results_1784264212273_1784264212414_9998aea9-6fa4-4a1f-aead-e79b1c835466.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/RIL_results_1784264212273_1784264212414_9998aea9-6fa4-4a1f-aead-e79b1c835466.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/RIL_results_1784264212273_1784264212414_9998aea9-6fa4-4a1f-aead-e79b1c835466.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/RIL_results_1784264212273_1784264212414_9998aea9-6fa4-4a1f-aead-e79b1c835466.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/RIL_results_1784264212273_1784264212414_9998aea9-6fa4-4a1f-aead-e79b1c835466.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/RIL_results_1784264212273_1784264212414_9998aea9-6fa4-4a1f-aead-e79b1c835466.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":196490,"url":"https:\/\/newslink360.space\/?p=196490","url_meta":{"origin":195138,"position":3},"title":"Jana Nayagan Box Office Collection Day 1 Worldwide Live Updates: Vijay film earns over Rs 80 crore","author":"Ajay Kumar Verma","date":"July 24, 2026","format":false,"excerpt":"Jana Nayagan box office collection day 1: Vijay's final film eyes Rs 100 crore mark.Jana Nayagan Box Office Collection Day 1 Live Update: Tamil Nadu Chief Minister and actor Vijay\u2019s last film Jana Nayagan finally hit theatres on July 23 to mixed reviews. At the box office, however, the movie\u2026","rel":"","context":"In &quot;National News&quot;","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/jana-nayagan-day-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/jana-nayagan-day-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/jana-nayagan-day-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/jana-nayagan-day-1.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/jana-nayagan-day-1.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/jana-nayagan-day-1.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":198044,"url":"https:\/\/newslink360.space\/?p=198044","url_meta":{"origin":195138,"position":4},"title":"Hardik Pandya to CSK? The IPL Trades That Actually Changed Everything","author":"Ajay Kumar Verma","date":"July 28, 2026","format":false,"excerpt":"Talk of Hardik Pandya swapping Mumbai blue for Chennai yellow has dominated this off-season\u2019s rumour mill, with MI reportedly angling for Ayush Mhatre and Shivam Dube (or Dewald Brevis) in return. Nothing\u2019s signed yet, but if it lands, it would rank among the IPL\u2019s most seismic trades \u2014 a fitting\u2026","rel":"","context":"In &quot;Sports&quot;","block_context":{"text":"Sports","link":"https:\/\/newslink360.space\/?cat=9"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/DSC_8014.JPG?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/DSC_8014.JPG?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/DSC_8014.JPG?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/DSC_8014.JPG?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/DSC_8014.JPG?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":194100,"url":"https:\/\/newslink360.space\/?p=194100","url_meta":{"origin":195138,"position":5},"title":"Do you also leave your toaster oven plugged in? Due to this mistake, 3 speechless people were burnt alive, there was a loss of Rs 1.5 crore.","author":"Ajay Kumar Verma","date":"July 17, 2026","format":false,"excerpt":"Powered by :Last Updated:July 17, 2026, 14:06 ISTThe switch of any electrical appliance should be removed from the plug socket immediately after using it. Not doing so could be dangerous. In America, an entire house was burnt to ashes due to the sudden switching on of a toaster plugged in.\u2026","rel":"","context":"In &quot;Top Stories&quot;","block_context":{"text":"Top Stories","link":"https:\/\/newslink360.space\/?cat=119"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/toster-2026-07-e975f688f750ce9960e7feab16e0a0d0-1200x675.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/toster-2026-07-e975f688f750ce9960e7feab16e0a0d0-1200x675.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/toster-2026-07-e975f688f750ce9960e7feab16e0a0d0-1200x675.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/toster-2026-07-e975f688f750ce9960e7feab16e0a0d0-1200x675.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/toster-2026-07-e975f688f750ce9960e7feab16e0a0d0-1200x675.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]}],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/pgnRh4-OLo","_links":{"self":[{"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/posts\/195138","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=195138"}],"version-history":[{"count":0,"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/posts\/195138\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/media\/195139"}],"wp:attachment":[{"href":"https:\/\/newslink360.space\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=195138"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=195138"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=195138"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}